Pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β) are elevated in IBD patients and can promote hepatic steatosis through multiple mechanisms, including increased hepatic lipogenesis, decreased fatty acid oxidation, and insulin resistance. Here, IL6 is linked to fatty liver disease.